Shevani Naidoo

The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies

Tomasz M. Beer, Kurt Miller, Bertrand Tombal et al. · European Journal of Cancer · 2017 · 37 citations

Quality Of Life, Life Assessment, Urology +12

Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews

Stefan Holmström, Shevani Naidoo, James Turnbull et al. · Patient · 2018 · 35 citations

Urology, Medicine, Qualitative Findings +4

Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial

Nancy Devlin, Michael Herdman, Marco Pavesi et al. · Health and Quality of Life Outcomes · 2017 · 33 citations · Full text

Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings

Erin Tomaszewski, Pierre Moïse, Robert Krupnick et al. · Patient · 2017 · 27 citations · Full text

Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan

Hiroyuki Okumura, Sachie Inoue, Shevani Naidoo et al. · Japanese Journal of Clinical Oncology · 2021 · 10 citations · Full text